Efficacy of a novel interferon alpha B/D, given in high dose. Monitored by quantitative HBeAg, HBsAg and HBV-DNA in patients with chronic hepatitis B.

被引：0
|
作者：
Rasch, MC
vanHattum, J
vanDijck, CMM
Haagsman, EB
Michielsen, P
Schellekens, H
机构：
[1] UNIV UTRECHT HOSP,DEPT GASTROENTEROL,UTRECHT,NETHERLANDS
[2] UNIV GRONINGEN HOSP,GRONINGEN,NETHERLANDS
[3] SSDZ,DELFT,NETHERLANDS
[4] UNIV HOSP,ANTWERP,BELGIUM
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [41] Efficacy of extended lamivudine therapy after HBV DNA breakthrough in Korean patients with chronic hepatitis B.
    Park, YH
    Suh, DJ
    Lee, HC
    Chung, YH
    Lee, YS
    HEPATOLOGY, 2002, 36 (04) : 643A - 643A
  • [42] Correlation between quantitative HBsAg and quantitative HBV DNA in chronic hepatitis B patients: a systematic review and meta-analysis
    Maimunah, Ummi
    Wardhani, Puspa
    Wungu, Citrawati Dyah Kencono
    Rahmanda, Anisa Firdausi
    Kurniawan, Andreas Agung
    Palayukan, Andrio
    EGYPTIAN LIVER JOURNAL, 2024, 14 (01)
  • [43] Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B:: HBsAg loss is associated with HBV genotype
    Flink, HJ
    van Zonneveld, M
    Hansen, BE
    de Man, RA
    Schalm, SW
    Janssen, HLA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02): : 297 - 303
  • [44] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
    Keshvari, Maryam
    Alavian, Seyed Moayed
    Sharafi, Heidar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)
  • [45] Quantification of HBsAg and HBV-DNA during Therapy with Peginterferon alpha-2b plus Lamivudine and Peginterferon alpha-2b Alone in a German Chronic Hepatitis B Cohort
    Wiegand, J.
    Brosteanu, O.
    Kullig, U.
    Wiese, M.
    Berr, F.
    Maier, M.
    Tillmann, H. L.
    Schiefke, I.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (11): : 1463 - 1469
  • [46] Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment
    Wu, Feng
    Wu, Min-Jin
    Zhuge, Xiao-Lin
    Zhu, Shao-Ming
    Zhu, Biao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (02) : 172 - 176
  • [47] Correlation of the occurrence of YMDD mutations with HBV genotypes,HBV-DNA levels,and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment
    Feng Wu
    Hepatobiliary&PancreaticDiseasesInternational, 2012, 11 (02) : 172 - 176
  • [48] Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA
    Martinot-Peignoux, Michelle
    Lapalus, Martine
    Laouenan, Cedric
    Lada, Olivier
    Netto-Cardoso, Ana Carolina Ferreira
    Boyer, Nathalie
    Ripault, Marie Pierre
    Carvalho-Filho, Roberto
    Asselah, Tarik
    Marcellin, Patrick
    JOURNAL OF CLINICAL VIROLOGY, 2013, 58 (02) : 401 - 407
  • [49] Quantification of the serum HBV-DNA and peripheral lymphocyte subsets during antiviral therapy in chronic hepatitis B.
    Fei, GZ
    Sylvan, SPE
    Yao, GB
    Hellström, UB
    HEPATOLOGY, 1998, 28 (04) : 217A - 217A
  • [50] Treatment with low-dose interferon-alpha in Bulgarian HBeAg-negative patients with chronic hepatitis B
    Krastev, Z
    Antonov, K
    Vassilev, M
    Jelev, D
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 27 (04) : 367 - 368
12345